Cited by 343Nitric Oxide and Endothelin EffectsLipoproteins and Cardiovascular HealthCardiovascular Health and Disease Prevention

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

Open access

Kaesemeyer, Wayne H., Caldwell, Ruth B., Huang, Jianzhong, Caldwell, R.William·1999·Journal of the American College of Cardiology

DOI 10.1016/s0735-1097(98)00514-2

Open this paper in CoChat — free account Open PDF

Abstract

Objectives We tested the hypothesis that pravastatin (PRA) activates endothelial nitric oxide synthase (eNOS).Background Pravastatin has been found to have clinical benefits beyond those predicted by its actions in reducing plasma low density lipoprotein cholesterol (LDL). Both PRA and simvastatin (SIM) are equally effective in reducing LDL, but only PRA reduces platelet aggregation and is an effective vasodilator. Nitric oxide (NO) also inhibits platelet aggregation and vasodilates.Methods We determined PRA and SIM effects on vasorelaxation in aortic rings and NO production by cultured bovine aortic endothelial cells. Nitric oxide was measured by using a NO electrode and by an assay for conversion of hemoglobin to methemoglobin. Specificity of NOS activation was tested by using the NOS inhibitor nitro-L-arginine methyl ester (L-NAME, 1 mmol/liter) in the presence or absence of excess L-arginine (L-ARG, 1 mmol/liter).Results Endothelium-dependent vasorelaxation was maximal with acetylocholine (ACH, 100%), followed by PRA (62.8%) and then SIM (37.1%). Direct measurement of NO confirmed that vasorelaxation is due to NO release and showed that PRA and ACH had similar dose-dependent effects on NO production, while SIM was only 25% to 30% as effective. Methemoglobin assay confirmed these results and demonstrated their specificity for NOS activity. The L-NAME blunted the responses to 45% of initial values. Excess L-ARG reversed this effect and potentiated NO production to 133% of initial levels.Conclusions Both PRA and SIM activate eNOS, but SIM is much less effective. Clinical benefits with PRA not explained by LDL reductions may be the result of an independent action of PRA on eNOS activation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(98)00514-2

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216
Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM
Tatti, P., Pahor, M., Byington, R. P., Mauro, P. D., Guarisco, R., Strollo, G., & Strollo, F. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.597 · Cited by 843
Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)
(1998) · Circulation · doi:10.1161/01.cir.97.15.1440 · Cited by 792
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
Pedersen, T. R., OLSSON, A. G., Færgeman, O., KJEKSHUS, J. K., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T. H., Þorgeirsson, G., Pyörälà, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 618
17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease
Collins, P. D., Rosano, G. M. C., Sarrel, P. M., Ulrich, L. G., Adamopoulos, S. N., Beale, C. M., McNeill, J. G., & Poole-Wilson, P. A. (1995) · Circulation · doi:10.1161/01.cir.92.1.24 · Cited by 530
Native Low-Density Lipoprotein Increases Endothelial Cell Nitric Oxide Synthase Generation of Superoxide Anion
Pritchard, K. A., Groszek, L., Smalley, D. M., Sessa, W. C., Wu, M., Villalon, P., Wolin, M. S., & Stemerman, M. B. (1995) · Circulation Research · doi:10.1161/01.res.77.3.510 · Cited by 470
Hydrophilicity/ lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors
Hamelin, B. A. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01147-4 · Cited by 468
Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase
Laufs, U., Fata, V. L., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31725 · Cited by 384

Show all 38 references

Research works printed but not linked: 3

Cockcroft, 1995, Nebivolol vasodilates human forearm vasculature, J Pharmacol Exp Ther, 274, 1067
Delanyi, 1996, S-Nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats, J Pharmacol Exp Ther, 279, 1174
Kaesemeyer, 1997, Nitrates supplemented with l-arginine for the reversal and treatment of nitrate tolerance, Appl Cardiopulmon Pathophys, 6, 255

Sorted by citations

Items 201–300 of 342

Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients
Sakabe, K., Fukuda, N., Wakayama, K., Nada, T., Shinohara, H., & Tamura, Y. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.08.001 · Cited by 18
“Hypercholesterolemia is commonly associated with impaired endothelial function, and enhanced endothelial function has been proposed to contribute to the cardiovascular benefits conferred by statins [31–36].”
Background
Effects of lipids on thrombotic mechanisms in atherosclerosis
Tousoulis, D., Davies, G., Ambrose, J. A., Tentolouris, C. A., Stefanadis, C., & Toutouzas, P. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00300-5 · Cited by 18
Pravastatin induces NO synthesis by enhancing microsomal arginine uptake in healthy and preeclamptic placentas
Pánczél, Z., Kukor, Z., Supák, D., Kovács, B. G., Kecskeméti, A., Czizel, R., Djurecz, M., Alasztics, B., Csomó, K. B., Hrabák, A., et al. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2507-0 · Cited by 17
Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction
Jurisic, A., Jurisic, Z., Lefkou, E. E., & Girardi, G. (2020) · Vascular Pharmacology · doi:10.1016/j.vph.2020.106824 · Cited by 17
Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis
Kückelhaus, C. D. S., Kückelhaus, S. A. S., & Muniz‐Junqueira, M. I. (2010) · Experimental Parasitology · doi:10.1016/j.exppara.2010.12.003 · Cited by 17
Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy
Egom, E. E. A., Rose, R. A., Neyses, L., Soran, H., Cleland, J. G. F., & Mamas, M. A. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.813013 · Cited by 17
Vascular Effects of Newer Cardiovascular Drugs: Focus on Nebivolol and ACE-Inhibitors
Lüscher, T. F., Spieker, L. E., Noll, G., & Cosentino, F. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200112003-00002 · Cited by 16
“Interestingly, cholesterollowering drugs increase NO synthase expression independent of their effects on lipid metabolism (79).”
Background
Effect of pitavastatin against expression of S100β protein in the gerbil hippocampus after transient cerebral ischaemia
Muramatsu, Y., Kurosaki, R., Kato, H., & Araki, T. (2004) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01300.x · Cited by 17
The Blood Fibrinolysis/Deep-Sea Analogy
Stief, T. W. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00213-9 · Cited by 17
Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)—A randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thickness
Markwood, T. T., Kent, S. M., Coyle, L. C., Flaherty, P. J., O’Malley, P. G., & Taylor, A. J. (2001) · American Heart Journal · doi:10.1067/mhj.2001.112784 · Cited by 17
Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide
Skogastierna, C., Luksha, L., Kublickiene, K. R., Eliasson, E., Rane, A., & Ekström, L. (2011) · Heart and Vessels · doi:10.1007/s00380-010-0097-x · Cited by 16
“It is important to note that although the HUVECs used in our experiments have venous features, the umbilical cord vein has the physiological role of conveying oxygenated, nutrient-rich ‘‘arterial blood’’ from the placenta to the fetus.”
BackgroundInfluential
Minimally modified (electronegative) LDL- and Anti-LDL- autoantibodies in diabetes mellitus and impaired glucose tolerance
Apolinário, E., Ferderbar, S., Pereira, E. C., Bertolami, M. C., Faludi, A. Á., Monte, O., Gagliardi, A. R. D. T., Xavier, H. T., & Abdalla, D. S. P. (2006) · Cited by 16
HMG-CoA Reductase Inhibitors Suppress the Development and Progression of Carotid Artery Intimal-medial Thickening in Hypercholesterolemic Type 2 Diabetic Patients
Takahashi, T., Ishii, N., Itai, K., Goto, R., Higashi, K., & Kobori, S. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.149 · Cited by 16
Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta1
Deng, H., & Xiong, Y. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00013.x · Cited by 16
Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats
Coelho‐Filho, O. R., Luca, I. M. S. D., Tanus-Santos, J. E., Cittadino, M., Sampaio, R., Coelho, O. R., Hyslop, S., & Moreno, H. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00423-5 · Cited by 16
Intravenous administration of pravastatin immediately after middle cerebral artery occlusion reduces cerebral oedema in spontaneously hypertensive rats
Mariucci, G., Taha, E., Tantucci, M., Spaccatini, C., Tozzi, A., & Ambrosini, M. V. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.04.002 · Cited by 15
Pharmacotherapy to improve outcomes in vascular access surgery: a review of current treatment strategies
Jackson, A. J., Coats, P., & Kingsmore, D. B. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr552 · Cited by 15
“Effects reported include inhibition of VSMC proliferation and migration [59], enhanced endothelial NO release [60] and reduced cytokine secretion [61].”
Background
Pravastatin‐induced proangiogenic effects depend upon extracellular FGF‐2
Shiota, M., Hikita, Y., Kawamoto, Y., Kusakabe, H., Tanaka, M., Izumi, Y., Nakao, T., Miura, K., Funae, Y., & Iwao, H. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01494.x · Cited by 15
Effects of cerivastatin on vascular function of human radial and left internal thoracic arteries
Nakamura, K., Al‐Ruzzeh, S., Chester, A. H., Schmidt, I., Barbir, M., Yacoub, M. H., & Amrani, M. (2002) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)03498-7 · Cited by 15
Physicians' interpretation of "class effects": a need for thoughtful re-evaluation.
Kennedy, H., & Rosenson, R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01913-7 · Cited by 17
“The role of specific statins on nitric oxide biosynthesis (68), smooth muscle cell synthesis of extracellular matrix and apoptosis (69–72), cytokine production by mononuclear cells (73), tissue factor biosynthesis (74) and perhaps other molecular and cellular mechanisms that stabilize plaque have come to the forefront.”
Background
Risk Factors for Early and Late Iliac Limb Occlusions of Stent Grafts Extending to the External Iliac Artery after Endovascular Abdominal Aneurysm Repair
Choi, E., Lee, S. A., Ko, G. Y., Kim, N., Cho, Y. P., Han, Y., & Kwon, T. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.06.028 · Cited by 14
Hydroxy-Methylglutaryl-Coenzyme A Reductase Inhibition Improves Endothelial Dysfunction in Type-1 Diabetes
Joyce, M., Moore, K., Thompson, C. J., Fitzgerald, P., Fennessy, F. M., Kelly, C., & Bouchier‐Hayes, D. J. (2004) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2003.12.020 · Cited by 14
Review: Statins and stroke
Rodríguez‐Yáñez, M., Agulla, J., Rodríguez‐González, R., Sobrino, T., & Castillo, J. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708091776 · Cited by 15
“Statins increase levels of NO by cholesterol-independent mechanisms [Laufs et al. 2002; Ozaki et al. 2001; Kaesemeyer et al. 1999; Hernandez-Perera et al. 1998].”
Background
Pravastatin and-L-arginine combination improves umbilical artery blood flow and neonatal outcomes in dichorionic twin pregnancies through an nitric oxide-dependent vasorelaxant effect
Jurisic, A., Jurisic, Z., Lefkou, E. E., Pombo, J., & Girardi, G. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.06.001 · Cited by 13
Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study
Cho, K. I., Kim, B. H., Park, Y. H., Ahn, J.-C., Kim, S., Chung, W., Kim, W., Sohn, I. S., Shin, J., Kim, Y. J., et al. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.05.007 · Cited by 13
Changes in the drug release pattern of fresh and set simvastatin-loaded brushite cement
Mestres, G., Kugiejko, K., Pastorino, D., Unosson, J., Öhman‐Mägi, C., Ott, M. K., Ginebra, M., & Persson, C. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.08.016 · Cited by 13
“1 M and heating it at 50 oC for 2 h [32].”
Background
Asymmetric dimethylarginine (ADMA) and acute vascular events
Valkonen, V.-P., & Laaksonen, R. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.05.020 · Cited by 13
Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?
Neal, D. A. J., & Alexander, G. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.27476 · Cited by 13
Drugs Modifying Nitric Oxide Metabolism Affect Plasma Cholesterol Levels, Coagulation Parameters, Blood Pressure Values and the Appearance of Plasma Myocardial Necrosis Markers in Rabbits: Opposite Effects of L-NAME and Nitroglycerine
Pinelli, A., Trivulzio, S., TOMASONI, L., Bertolini, B., Brenna, S., Bonacina, E., & Accinni, R. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1024299523852 · Cited by 13
Markers of the Acute Phase Response in Cardiovascular Disease: An Update
Whicher, J. T., Rifai, N., & Biasucci, L. M. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.171 · Cited by 13
“Various members of this drug class have potential anti-inflammatory properties including increasing nitric oxide and anti-oxidant activity and suppressing smooth muscle and mononuclear cell proliferation (65).”
Background
The significance of lipid peroxidation in cardiovascular disease
Siegel, G., Ermilov, E. A., Pries, A. R., Winkler, K., Schmidt, A., Ringstad, L., Malmsten, M., & Lindman, B. (2013) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2013.05.022 · Cited by 12
Effect of Atorvastatin-Eluting Stents in a Rabbit Iliac Artery Restenosis Model
Lim, K. S., Jeong, M. H., Bae, I., Park, J., Park, D. S., Kim, J. M., Kim, J. H., Cho, D. L., Sim, D. S., Park, K. H., et al. (2013) · Chonnam Medical Journal · doi:10.4068/cmj.2013.49.3.118 · Cited by 12
“The basis for this benefit is a mechanism of early acute direct activation of endothelial nitric oxide synthase, which is neither cholesterol nor HMG-CoA reductase dependent.(24) We suspect that statins suppress the delayed arterial healing effect of the Taxol family and -limus derivatives.”
Background
Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia
On behalf of the PERSPECTIVA Study Group, Sirenko, Y., & Radchenko, G. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0184-5 · Cited by 12
Bioconversion of mevastatin to pravastatin by various microorganisms and its applications – A review
Syed, M. B., & Ponnusamy, T. (2017) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2017.11.002 · Cited by 13
Advances in Lipid-Lowering Therapy in Atherosclerosis
Davignon, J. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1321-6_8 · Cited by 12
Early Benefits of Pravastatin to Experimentally Induced Atherosclerosis
da Silva, E. P., Fonseca, F. A. H., Ihara, S. S. M., Izar, M. C. D. O., Lopes, I. E. L., Pinto, L. E. S. A., Badimón, J. J., Tuffik, S., Paiva, T. B., Kasinski, N., et al. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200203000-00010 · Cited by 12
“(26) The recovery of endothelial function seems very important in the reduction of clinical events due to the importance of nitric oxide not only in the vasoreactivity but also reducing thrombotic risk, inflammation, and cell proliferation (9,10,21,27).”
Background
Protective effect of pitavastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, on ischemia-induced neuronal damage
Kurosaki, R., Muramatsu, Y., Kato, H., & Araki, T. (2004) · Neurological Research · doi:10.1179/016164104225014102 · Cited by 12
Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats
Hsu, S., Wang, S.-S., Hsin, I., Huang, H., Lee, F., Lee, J.-Y., Lin, H., Chuang, C., & Lee, S. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.711851 · Cited by 11
“Moreover, the possibility that statins act as direct NO agonists has been supported by studies on aortic rings of rats: the enhanced relaxation in response to pravastatin and simvastatin was observed immediately after exposure for 10min, whichwas blunted byL-NAME (N-nitroL-arginine methyl ester) [30].”
Background
The Antihypertensive Actions of Statins: Modulation by Salt Intake
Juncos, L. I., Juncos, L. A., & Garcia, N. H. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.105 · Cited by 11
Inflammation and Infection in Acute Coronary Syndromes
Albert, N. M. (2000) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200010000-00003 · Cited by 11
Effect of pravastatin on responsiveness to N-monomethyl-l-arginine in patients with hypercholesterolaemia
Bayerle‐Eder, M., Fuchsjäger‐Mayrl, G., Sieder, A. E., Polska, E., Roden, M., Stulnig, T. M., Bischof, M. G., Waldhäusl, W. K., Schmetterer, L. F., & Wolzt, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00559-7 · Cited by 11
The impact of statins on wound healing: an ally in treating the highly comorbid patient
Hawa, A. A. A. E., Klein, D., Bekeny, J. C., Severin, J. H., Zolper, E. G., Tefera, E., Evans, K. K., Fan, K. L., & Attinger, C. E. (2022) · Journal of Wound Care · doi:10.12968/jowc.2022.31.sup2.s36 · Cited by 10
Statins – are they potentially useful in rheumatology?
Bielińska, A., & Głuszko, P. (2007) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.206 · Cited by 10
“The increase of endothelial expression of nitric monoxide production catalyzing enzyme takes place through the Rho protein inhibition (guanosine triphosphate GTP small binding protein) and Akt, protein kinase [12].”
Background
The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin
Liu, X., Ma, D., Zheng, S., Zha, K., Feng, J., Cai, Y., Jiang, F., Li, J., & Fan, Z. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000012 · Cited by 10
Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease
Ceri̇t, L., Duygu, H., Gülşen, K., & Günsel, A. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0883-x · Cited by 10
Pharmacological therapies, lifestyle choices and nitric oxide deficiency: A perfect storm
Bryan, N. S. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.009 · Cited by 10
Direct inhibition by a statin of TNFα-induced leukocyte recruitment in rat pial venules — in vivo confocal microscopic study
Obama, R., Ishida, H., Takizawa, S., Tsuji, C., Nakazawa, H. K., & Shinohara, Y. (2004) · Pathophysiology · doi:10.1016/j.pathophys.2004.07.001 · Cited by 10
Spontaneous spasm of the arterial duct: a pitfall for transcatheter occlusion
Tzifa, A. (2004) · Heart · doi:10.1136/hrt.2004.035147 · Cited by 9
The influence of statins on the free intracellular calcium concentration in human umbilical vein endothelial cells
Heinke, S., Schwarz, G., Figulla, H. R., & Heinemann, S. H. (2004) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-4-4 · Cited by 9
“Further it was shown that pravastatin and simvastatin increased the endothelium-dependent vasorelaxation in aortic rings and also the NO production by cultured bovine aortic endothelial cells [8].”
Vascular and Endothelial Actions of Inhibitors of Substance P Amidation
Abou-Mohamed, G., Huang, J., Oldham, C. D., Taylor, T. A., Jin, L., Caldwell, R. B., May, S. W., & Caldwell, R. W. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200006000-00007 · Cited by 9
Statins and stroke
Tong, D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a9fad1 · Cited by 8
Statins as coronary vasodilators in isolated bovine coronary arteries—involvement of PGI2 and NO
Lorkowska, B., & Chłopicki, S. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.10.012 · Cited by 8
Synthesis and characterization of a poly(ethylene glycol)–poly(simvastatin) diblock copolymer
Asafo-Adjei, T. A., Dziubla, T. D., & Puleo, D. A. (2014) · RSC Advances · doi:10.1039/c4ra10310f · Cited by 8
Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease
van Koppen, A., Papazova, D. A., Oosterhuis, N. R., Gremmels, H., Giles, R. H., Fledderus, J. O., Joles, J. A., & Verhaar, M. C. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0064-7 · Cited by 8
“Induction of improvement in CKD BMC function by HMGCR inhibition within 2 hours is remarkable but seems consistent with previous reports showing that short-term statin incubation (<10 minutes) induces a rapid elevation of NO production in endothelial cells [35] and rapid (<30 minutes) induction of Akt-mediated phospho…”
Result
Pleiotropic and Lipid and #8211;lowering Effects of Statins in Hypertension
Kamberi, L., Bakalli, A., Budima, N., Gorani, D., Karabulut, A., & Pallaska, K. (2012) · Materia Socio Medica · doi:10.5455/msm.2012.24.84-86 · Cited by 8
Pravastatin Protection from Cold Stress in Myocardium of Rats.
Bombig, M. T. N., Ferreira, C., Mora, O. A., Soares, J. D., Póvoa, R., Filho, B. L., Simões, M. D. J., Filho, C. F., Murad, N., & da Costa, A. R. (2003) · Japanese Heart Journal · doi:10.1536/jhj.44.243 · Cited by 8
Pravastatin
Bang, L. M., & Goa, K. L. (2003) · Drugs & Aging · doi:10.2165/00002512-200320140-00005 · Cited by 8
Statins and the Role of Nitric Oxide in Chronic Heart Failure
von Haehling, S., Anker, S. D., & Bassenge, E. (2004) · Springer eBooks · doi:10.1007/1-4020-7960-5_16 · Cited by 8
The beneficial in vitro effects of lovastatin and chelerythrine on relaxatory response to acetylcholine in the perfused mesentric bed isolated from diabetic rats
Fatehi‐Hassanabad, Z., Imenshahidi, M., Fatehi, M., Farrokhfall, K., & Heidar, P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.063 · Cited by 8
Combined Statin and Glucocorticoid Therapy for the Safer Treatment of Preterm Birth
Kane, A. D., Herrera, E. A., Niu, Y., Camm, E. J., Allison, B. J., Tijsseling, D., Lusby, C., Derks, J. B., Brain, K. L., Bronckers, I. M. G. J., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.19647 · Cited by 7
Endothelium Modulates Contractile Response to Simvastatin in Rat Aorta
Pérez‐Guerrero, C., de Sotomayor, M. Á., Herrera, M. D., & Marhuenda, E. (2000) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2000-1-222 · Cited by 7
The HMG-CoA Reductase Inhibitor Cerivastatin Enhances the Nitric Oxide Bioavailability of the Endothelium
Berkels, R., Nouri, S. K., Taubert, D., Bartels, H., Roesen, P., Roesen, R., & Klaus, W. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200309000-00006 · Cited by 7
Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
Šebeštjen, M., Boh, M., & Keber, I. (2002) · PubMed · Cited by 7
The expanding role of HMG-CoA reductase inhibitors (statins) in the prevention and treatment of ischemic heart disease
CHILTON, R. J., & O’Rourke, R. A. (2001) · Current Problems in Cardiology · doi:10.1067/mcd.2001.119386 · Cited by 7
UNSTABLE ANGINA – A DEFINITIVE ROLE FOR STATINS IN SECONDARY PREVENTION
Colquhoun, D. (2000) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2000.tb11927.x · Cited by 7
Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women
Ushiroyama, T., Nosaka, S., & Ueki, M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.11.001 · Cited by 6
Bone marrow mononuclear cells enhance anti-inflammatory effects of pravastatin against isoproterenol-induced myocardial infarction in rats
El‐Mahdy, N. A., Salem, M. L., El‐Sayad, M. E., El-Desouky, K. I., & Zaghow, N. (2015) · Journal of Immunotoxicology · doi:10.3109/1547691x.2015.1111959 · Cited by 6
“Previous studies demonstrated the ability of statins to up-regulate eNOS activity and NO production by increasing eNOS mRNA stability (Kaesemeyer et al. 1999).”
Background
Porous Composite Granules with Potential Function of Bone Substitute and Simvastatin Releasing System: A Preliminary Study
Laskus, A., Kazimierczak, P., & Kolmas, J. (2021) · Materials · doi:10.3390/ma14175068 · Cited by 6
“The route of the hydrolysis reaction is described elsewhere [14,18] and presented in Figure 1.”
BackgroundMethodInfluential
Pravastatin Decreases Infarct Size Induced by Coronary Artery Ischemia/Reperfusion with Elevated eNOS Expression in Rats
He, L., Wang, C., Sun, J., Liu, C., Li, N., & Chen, J. (2018) · International Heart Journal · doi:10.1536/ihj.16-607 · Cited by 6
Effect of atorvastatin on impaired vascular function in healthy old men
Weverling‐Rijnsburger, A. W. E., Blauw, G. J., & Meinders, A. E. (2004) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00548.x · Cited by 6
“Although there is evidence that statins might have a direct effect on endothelial-dependent vasodilatation, for example, via activation of nitric oxide synthase (7, 22), human data on these ‘direct’ effects of statins on endothelial function are scarce.”
Background
Elderly Patients at Risk for Coronary Heart Disease or Stroke: Selecting an Ideal Product for Lipid Lowering
Rackley, C. E. (2001) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2001.00838.x · Cited by 6
Enhanced Neuroprotective Synergy of Atorvastatin and Magnesium L-Threonate in a Rat Model of Alzheimer’s Disease Induced by Aluminum Chloride
Gangoda, D. M., Saiyed, M. S., Pathan, S. R., Sharma, K. B., Patel, V. A., Sachdeva, P. D., Patel, M. Y., & Patel, M. D. (2023) · Cureus · doi:10.7759/cureus.48400 · Cited by 5
“These effects include reducing A β production, suppressing inflammation, protecting neurons, promoting synaptogenesis, and enhancing vasodilation through increased eNOS and decreased endothelin-1 [31-33].”
Background
Contrast-induced nephropathy: do statins offer protection?
Sadat, U. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283470340 · Cited by 5
Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats
Chang, C.-C., Wang, S.-S., Huang, H., Lee, J., Lee, F., Lin, H., & Lee, S. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06170.x · Cited by 5
The Effect of Chunghyul‐Dan on Hyperventilation‐Induced Carbon Dioxide Reactivity of the Middle Cerebral Artery in Normal Subjects: A Dose‐Dependent Study
Jin, C., Moon, S., Cho, S., Park, S.-U., Jung, W., Park, J., Ko, C., Cho, K., & Kwon, S. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/4567217 · Cited by 5
“[37] reported that statins rapidly activate eNOS in bovine aortic endothelial cells and lead to the production of NO.”
Background
Relaxant effect of atorvastatin on isolated rat gastric fundus strips: implications for Ca2+-signalling mechanisms
Durman, D. K., Yildirim, I. A., Özdemir, O., & Uydeş-Doğan, B. S. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0723 · Cited by 5
Chronic Treatment with Fluvastatin Improves Smooth Muscle Dilatory Function in Genetically Determined Hyperlipoproteinemia
Perings, S. M., Grubert, N., Kleinbongard, P., Reinecke, P., Schulz, R., Hermsen, D. F., Willers, R., & Kelm, M. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200402000-00004 · Cited by 5
Cerivastatin and hypercholesterolemia reduce apoptosis of cardiomyocytes in guinea pig papillary muscle subjected to hypoxia/reoxygenation.
Dworakowski, R., Dorota Dworakowska, B., Kocić, I., Wirth, T., Gruchała, M., Kamiński, M., Petrusewicz, J., Ylä‐Herttuala, S., & Rynkiewicz, A. (2006) · PubMed · Cited by 5
Estatinas en el tratamiento de la hipertensión arterial
Carrasco, J. M., Urrestarazu, R. A., & Peláez, B. A. (2002) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(02)71326-3 · Cited by 5
Molecular mechanism of vasorelaxant and antiatherogenic effects of the statins in the human saphenous vein graft
Döndaş, N. Y., Sucu, N., Yılmaz, B. C., Kaplan, H. M., Özeren, M., Karaca, M. K., Vezir, Ö., & Singirik, E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.013 · Cited by 4
Pharmacotherapy to Improve Outcomes in Infrainguinal Bypass Graft Surgery: A Review of Current Treatment Strategies
Jackson, A. J., Coats, P., Orr, D. J., Teenan, R. P., & Wadsworth, R. M. (2010) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2010.02.028 · Cited by 4
Acute Effect of Cerivastatin on Cardiac Regional Ischemia in a Rat Model Mimicking Off-Pump Coronary Surgery
Nakamura, K., Al‐Ruzzeh, S., Ilsley, C. D. J., Yacoub, M. H., & Amrani, M. (2005) · Journal of Cardiac Surgery · doi:10.1111/j.1540-8191.2005.00139.x · Cited by 4
HMG-CoA Reductase Inhibition in the Treatment of Atherosclerosis: Effects Beyond Lipid Lowering
März, W., & Br, W. (2002) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 4
Statin drug eluting stent (DES) for early stent thrombosis
Kaesemeyer, W. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.026 · Cited by 4
Can the premises of the altered homeostatic theory permit improvement in the prevention of ischemic heart disease?
Hellstrom, H. R. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00328-6 · Cited by 4
Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed
İlhan, E., Büyükafşar, K., Tiftik, R. N., Seçilmiş, M. A., & Alzayed, Z. (2021) · Balkan Medical Journal · doi:10.5152/balkanmedj.2021.20014 · Cited by 3
Design of gelatin cryogel scaffolds with the ability to release simvastatin for potential bone tissue engineering applications
Yaman, S. M., Demir, D., & Bölgen, N. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad651e · Cited by 3
“Then, the solution was neutralized to pH 7.2 with 0.1 M HCl, stored frozen at − 20 ◦ C, and freeze-dried by lyophilization [36, 37].”
Influential
Hyperlipidaemia and cardiovascular disease
Le, N. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00016 · Cited by 3
Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome
Brillante, D., O’Sullivan, A., Brillante, R., & Howes, L. G. (2009) · Blood Pressure · doi:10.1080/08037050902982284 · Cited by 3
Hydroxymethylglutaryl co-enzyme A reductase inhibition attenuates endotoxin-mediated inflammatory responses
Joyce, M., Casey, R. G., Gang, C., Winter, D. C., Kelly, C., & Bouchier‐Hayes, D. J. (2005) · British journal of surgery · doi:10.1002/bjs.4985 · Cited by 3
Prevention of a First Myocardial Infarction
Dayspring, T. D. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010203 · Cited by 3
“The results could not be explained by lipid lowering alone.(55)”
Background
Pravastatin treatment causes a shift in the balance of hippocampal neurotransmitter binding densities towards inhibition
Müller, H. D., Berger, C., Schwab, S., & Sommer, C. (2009) · Brain Research · doi:10.1016/j.brainres.2009.12.032 · Cited by 3
History and development of HMG-CoA reductase inhibitors
Bellosta, S., Paoletti, R., & Corsini, A. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8135-7_1 · Cited by 4
“... [25] Inhibition of cell adhesion [91] Inhibition of tissue factor expression and activity [92] Inhibition of superoxide generation [93] Decreased platelet activation [94] Inhibition of leukocyte-endothelium adhesion [95] Inhibition of chemokine and MCP-I secretion [96-98] Increased fibrinolytic activity [99] Induc…”
Background
Antioxidative eVects of statins
Adam, O., & Laufs, U. (2008) · Cited by 3
Myocardial Blood Flow Measurement
Schindler, T. H., Valenta, I., & Schelbert, H. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05796-7.00065-5 · Cited by 2
Effects of simvastatin on blood pressure in hypercholesterolemic patients: An open-label study in patients with hypertension or normotension
Branchi, A., Fiorenza, A. M., Torri, A., Berra, C., Colombo, E., Rovellini, A., & Sommariva, D. (2004) · Current Therapeutic Research · doi:10.1016/s0011-393x(04)80057-2 · Cited by 2
Differential Effect of Cerivastatin and L-Arginine on the Vascular Function of Human Radial and Left Internal Thoracic Arteries
Nakamura, K., Al‐Ruzzeh, S., Chester, A. H., Ilsley, C. D. J., Yacoub, M. H., & Amrani, M. (2005) · Journal of Cardiac Surgery · doi:10.1111/j.0886-0440.2005.200350.x · Cited by 2
How to Choose a Statin After Kidney Transplantation: Case Analyses
Mucha, K., Foroncewicz, B., Ołdakowska‐Jedynak, U., Sołdacki, D., Kryst, P., & Pączek, L. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.12.005 · Cited by 2
Fluorescence spectroscopic analysis of circulating platelet activation during coronary angioplasty
Christov, A. M., Kostuk, W. J., Jablonsky, G., & Lucas, A. R. (2001) · Lasers in Surgery and Medicine · doi:10.1002/lsm.1069 · Cited by 2
“Lovastatin #[74] #[77] Nitroglycerin #[78] #[69] #[69] #[78] Pravastatin #[79]”
Effects of an HMG-CoA Reductase Inhibitor in Combination with an ACE Inhibitor or Angiotensin II Type 1 Receptor Antagonist on Myocardial Metabolism in Ischemic Rabbit Hearts
Kawabata, H., Nakagawa, K., & Ishikawa, K. (2002) · Hypertension Research · doi:10.1291/hypres.25.203 · Cited by 2
“Recent studies have suggested that HMG-CoA reductase inhibitors activate endothelial nitric oxide synthase (eNOS) independently of its effects on lipids (4, 5).”
Background

Authors: Kaesemeyer, W. H., Caldwell, R. B., Huang, J., & Caldwell, R. W.
Affiliations: Augusta University (US)
Corresponding author: Kaesemeyer, Wayne H.
ORCID: Kaesemeyer, Wayne H.
Caldwell, Ruth B.
Huang, Jianzhong
Caldwell, R.William
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 1999-01
Volume: 33
Issue: 1
Pages: 234-241
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/s0735-1097(98)00514-2
OpenAlex: W2169537677
Cited by: 343
References: 38
Citations by year: 2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 8 · 2016: 8 · 2015: 7 · 2014: 8 · 2013: 10 · 2012: 9
FWCI: 19.26
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5310 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: Bristol-Myers Squibb
Topics: Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords: pravastatin, simvastatin, endothelial nitric oxide synthase, nitric oxide, endothelium-dependent relaxation, platelet aggregation, vasodilation, L-NAME, L-arginine, statins, LDL cholesterol lowering, aortic endothelial cells
MeSH terms: Animals, Anticholesteremic Agents, Cattle, Endothelium, Vascular, Enzyme Activation, Cholesterol, LDL, Male, Platelet Aggregation, Vasodilation, Pravastatin, Rats, Sprague-Dawley, Nitric Oxide Synthase, Culture Techniques, Rats, Nitric Oxide Synthase Type III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks